Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
- Institution
- VOLUMETRIX, LLC, TN
- Principal investigator
- Kyle Mitchell Hocking
- Funding
- $1.0M
- Duration
- 2018–2026
Moonbase score
Still being scored
Abstract
Project Summary Volume overload (congestion) occurs in patients with heart failure (HF) and is the leading cause of hospitalization in the elderly worldwide. Unfortunately, clinical signs and symptoms; laboratory values; and existing diagnostic tools are unreliable in providing accurate assessment of volume status. Using a unique physiologic signal, Non-Invasive Venous waveform Analysis (NIVA), VoluMetrix has developed a proprietary device and algorithm designed for monitoring volume status in HF patients. Proof of concept data in humans and experimental animal models, demonstrate that NIVA provides a reliable indication of intravascular volume status (“pulmonary capillary wedge equivalent”). The work in this Phase IIB proposal will establish interface and usability studies to complete the process necessary for bridging the gap to commercialization.
Research team
- Kyle Mitchell HockingPI
- Joann LindenfeldPI
LOADING MOONBASE SCORE
Questions for Volumetrix, Llc
Volumetrix, Llc hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same researchers, same topic, scored first.
- NIH · Volumetrix, LlcNot yet scored
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
Kyle Mitchell Hocking · $176K · 2018–2026
- NIH · Vanderbilt University Medical CenterNot yet scored
Non-Invasive Venous waveform Analysis (NIVA) for Monitoring Volume Status in Heart Failure Patients
Bret D Alvis · $436K · 2019–2029
- NIH · Duke UniversityNot yet scored
Splanchnic Nerve Modulation In Heart Failure (Splanchnic X)
Marat Fudim · $591K · 2024–2029